Americas vs France: Proportion of the target population who received a 3rd dose of
Americas
79.0%
in 2024
France
96.0%
in 2024
Americas rank
14th
France rank
16th
Proportion of the target population who received a 3rd dose of over time
- Americas
- France
How they compare
France currently reports 96.0% against 79.0% in Americas, a difference of 17.0%.
That makes France's figure about 1.2 times Americas's.
Across all 15 years both countries report, France has been ahead every year.
Americas ranks 14th and France ranks 16th of 37 groups.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas | France | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.2% | 90.5% | 13.3% | France |
| 2020s | 76.4% | 95.6% | 19.2% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Americas or France?
- France, at 96.0% against 79.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Americas and France?
- 17.0%, with France ahead.
- How many years of comparable data are there for Americas and France?
- 15 years are reported by both, from 2010 to 2024.
- How do Americas and France rank globally for proportion of the target population who received a 3rd dose of?
- Americas ranks 14th and France ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.